WINDSOR, CT — SCA Pharma, a recognized leader in the field of sterile compounding, will be one of the sponsors of the Health Connect Partners (HCP) Fall 2019 Hospital Pharmacy Conference Oct. 28-30, in Kansas City, MO.
SCA Pharma CEO Milton Boyer will speak on the topic “What does cGMP really mean?” Any registered providers can attend the talk, which will take place Monday, Oct. 28, at 4:30 p.m. in the Atlanta ballroom of the Sheraton Kansas City Hotel at Crown Center.
SCA Pharma is an FDA 503B outsourcing facility providing the highest quality sterile admixtures and pre-filled syringes. Licensed in all 50 states, SCA Pharma specializes in preparing sterile pharmaceuticals customized for hospital pharmacies and healthcare facilities nationwide.
Headquartered in Little Rock, Ark., SCA Pharma has two state-of-the-art production facilities in Arkansas and Connecticut.
The HCP conference offers a venue for networking with colleagues, attending continuing education sessions and learning about the latest in clinical, technological, and regulatory information available in the practice of hospital pharmacy.
SCA team members will be on hand at the conference to discuss the company’s robust catalog of products and quality initiatives. To schedule a meeting during the conference, contact email@example.com.
This post is related to:Admixture Compounding Services (503B Outsourcing Facilities)